Gemphire Therapeutics Inc. (GEMP): Price and Financial Metrics


Gemphire Therapeutics Inc. (GEMP): $7.50

-0.03 (-0.40%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

GEMP Stock Price Chart Interactive Chart >

Price chart for GEMP

GEMP Price/Volume Stats

Current price $7.50 52-week high $8.50
Prev. close $0.30 52-week low $0.24
Day low $7.26 Volume 7,640
Day high $8.50 Avg. volume 127,174
50-day MA $0.34 Dividend yield N/A
200-day MA $0.71 Market Cap 111.54M

Gemphire Therapeutics Inc. (GEMP) Company Bio


Gemphire Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of dyslipidemia cardiovascular disease. The company was founded in 2008 and is headquartered in Northville, Michigan.


GEMP Latest News Stream


Event/Time News Detail
Loading, please wait...

GEMP Latest Social Stream


Loading social stream, please wait...

View Full GEMP Social Stream

GEMP Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year -95.39%
YTD N/A
2022 N/A
2021 N/A
2020 N/A
2019 0.00%
2018 -89.80%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6956 seconds.